Targeted α particle immunotherapy for myeloid leukemia

…, JL Humm, MW Brechbiel, R Molinet… - Blood, The Journal …, 2002 - ashpublications.org
Unlike β particle–emitting isotopes, α emitters can selectively kill individual cancer cells with
a single atomic decay. HuM195, a humanized anti-CD33 monoclonal antibody, specifically …

Production of Ac-225 from Th-229 for targeted α therapy

C Apostolidis, R Molinet, G Rasmussen… - Analytical …, 2005 - ACS Publications
This work describes a method for the separation and purification of Ac-225 from a Th-229
source. The procedure is based on the combination of ion exchange and extraction …

[PDF][PDF] Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry

…, MW Geerlings, C Apostolidis, R Molinet… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Results: Radiolabelingefficiencyof the CHX-A-DTPA-HuM195 construct with 213Biwas 78%
±10%(n= 46) after 10 min at specific activities of up to 1110MBq/mg. The immunoreactivity …

Cyclotron production of Ac-225 for targeted alpha therapy

C Apostolidis, R Molinet, J McGinley, K Abbas… - Applied Radiation and …, 2005 - Elsevier
The feasibility of producing Ac-225 by proton irradiation of Ra-226 in a cyclotron through the
reaction Ra-226(p,2n)Ac-225 has been experimentally demonstrated for the first time. …

High-linear energy transfer (LET) α versus low-LET β emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi-versus …

…, MG Stabin, E Wehrmann, C Apostolidis, R Molinet… - Cancer research, 1999 - AACR
Recent studies suggest that radioimmunotherapy (RIT) with high-linear energy transfer (LET)
radiation may have therapeutic advantages over conventional low-LET (eg., β − ) emissions…

Single-column extraction chromatographic separation of U, Pu, Np and Am

…, R Carlos-Marquez, K Mayer, R Molinet - Radiochimica …, 2002 - degruyter.com
A rapid, single-column extraction chromatographic method using commercially available
UTEVA resin has been developed for the separation of uranium, plutonium, neptunium and …

Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with β …

…, RD Blumenthal, C Apostolidis, R Molinet… - Clinical cancer …, 1999 - AACR
Usually, the red marrow (RM) is the first dose-limiting organ in radioimmunotherapy. However,
several studies have obtained only poor correlations between the marrow doses and the …

In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis …

…, F Offner, J Philippé, C Apostolidis, R Molinet… - European journal of …, 2003 - Springer
External source radiotherapy and beta radioimmunotherapy (RIT) are effective treatments for
lymphoid malignancies. The development of RIT with alpha emitters is attractive because of …

Separation of 248Cm from a 252Cf neutron source for production of Cm targets

…, C Apostolidis, R Carlos, JP Glatz, R Molinet… - Radiochimica …, 2001 - degruyter.com
The separation of milligram amounts of 248 Cm from 252 Cf is presented. Essentially
isotopically pure 248 Cm was obtained from an "old" 252 Cf neutron source by acid leaching. …

Development and validation of a simple, rapid and robust method for the chemical separation of uranium and plutonium

C Apostolidis, R Molinet, P Richir, M Ougier… - Radiochimica …, 1998 - degruyter.com
A simple and robust method was developed for the chemical separation of uranium and
plutonium from mixed U/Pu/fission product solutions. The method is based on a commercially …